Skip to content
value.today
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. is listed today as Anavex Life Sciences Corp.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Anavex Life Sciences Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2014$10 MPrivate placement after listing$10 to $50 million

Anavex Life Sciences Corp.: Private sale, Mar 2014

Investors in this round

11 investors had bought by the notice of Apr 2, 2014: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$106,800
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$700,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Christopher U. Missling · Executive Officer, Director
  • Athanosios U. Skarpelos · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in CA, NJ, NY

Signed by Christopher U. Missling, PhD, Ceo. Source: SEC Form D, newest notice filed Apr 2, 2014. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Anavex Life Sciences Corp. chose not to state its revenue in its newest notice of a funding round (Apr 2014).

    SEC Form D · Apr 2014

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2014

That is all the official record says: Anavex Life Sciences Corp. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Anavex Life Sciences Corp. are on record.

Investors#

No investor of Anavex Life Sciences Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Anavex Life Sciences Corp. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Anavex Life Sciences Corp.
NameRoleNamed in
Christopher U. MisslingExecutive officerApr 2014
Athanosios U. SkarpelosDirectorApr 2014
Christopher U. MisslingDirectorApr 2014

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.